# Northrop Grumman Corporation (NOC) — Investment Thesis

**Exchange:** NYSE  
**Coverage as of:** 2026-Q2  
**Updated:** 2026-05-12  
**Tier:** Free primer (steps 1 & 3 of 19)  
**Sibling pages:** /stocks/NOC/financials · /stocks/NOC/memo

> This page shows the free thesis context (business model + recent catalysts).
> The full investment thesis (moat analysis, DCF, scenarios, risk register) is available
> via GET /api/v1/research/NOC/memo ($2.00, Bearer token).

## Business Model

---
ticker: NOC
step: 01
generated: 2026-05-12
source: quick-research
---

### Northrop Grumman Corporation (NOC) — Business Overview

#### Business Description
Northrop Grumman is one of the top-5 US defense primes (alongside Lockheed Martin, RTX, General Dynamics, Boeing), uniquely positioned at the intersection of **strategic deterrence** (B-21 Raider next-gen stealth bomber + LGM-35A Sentinel ICBM), **space systems** (national security space, missile defense), **mission systems** (radar, sensors, cyber, electronic warfare), and **defense systems** (munitions, weapons). The company is led by CEO Kathy Warden. FY25 revenue ~$44B; record $95.7B backlog. The **B-21 Raider production ramp** (25% acceleration agreement) + **Sentinel ICBM restructuring** + **CCA / autonomous systems** + **munitions expansion** create a multi-year "Deterrence Super-Cycle" thesis with material upside in 2027-28.

#### Revenue Model
Four reportable segments (FY2025 revenue):
- **Aeronautics Systems** ($12.99B, ~29%, +8%) — B-21 Raider, B-2 Spirit, F-35 (sub-contract), Triton/Global Hawk surveillance UAS, X-47 autonomy, E-2D Hawkeye.
- **Mission Systems** ($12.51B, ~29%, +9.7%) — Radar (APG-83, APG-81 for F-35), electronic warfare (SEWIP), C4I, advanced computing, cyber, naval weapons.
- **Space Systems** ($10.77B, ~25%, -8.2%) — Sentinel ICBM (LGM-35A), national security space, NGAD space components, Cygnus cargo (ISS), missile defense (NGI Next Generation Interceptor).
- **Defense Systems** ($8.00B, ~18%) — Munitions, weapons, ground combat, propellants, fire-control.

Revenue is overwhelmingly long-cycle (multi-year cost-plus + fixed-price contracts) with US Government as ~80%+ customer.

#### Products & Services
- **B-21 Raider Stealth Bomber**: Successor to B-2; 25% production acceleration agreement; multi-decade program. Combat-ready 2029.
- **Sentinel ICBM (LGM-35A)**: Replaces Minuteman III; under restructuring through late 2026; test launch 2027; operational early 2030s. $200M near-term + $2.5B multi-year capex commitment.
- **Triton + Global Hawk UAS**: Maritime + high-altitude surveillance.
- **Cygnus**: ISS cargo resupply (NASA).
- **NGI (Next Generation Interceptor)**: Missile defense; competing with Lockheed.
- **Collaborative Combat Aircraft (CCA)**: Autonomous wingmen for F-35/NGAD; emerging program with material 2027-28 upside.
- **APG-83 + APG-81 AESA radars**: F-16 + F-35 fighter radars.
- **SEWIP**: Surface Electronic Warfare Improvement Program (Navy).
- **Munitions / Weapons**: AARGM-ER, AGM-88E, Stand-In Attack Weapon (SiAW); munitions expansion driven by Ukraine + Israel + Pacific demand.

#### Customer Base & Go-to-Market
- **US Department of Defense** (~80% of revenue): All military services + DARPA + Missile Defense Agency.
- **NASA** (~5%): Cygnus + space science programs.
- **Foreign Military Sales** (~15%): Various NATO + Pacific allies (Australia, Japan, Korea).
- **Commercial**: Smaller; mostly Cygnus + small business spinoffs.

Distribution: Direct US government contracts; foreign military sales via Government channels; multi-year cost-plus + fixed-price agreements.

#### Competitive Position
Northrop occupies a unique niche in US defense — the **dominant stealth bomber + ICBM + national security space prime**:

1. **B-21 Raider sole-source** — Only fifth-generation stealth bomber in development; multi-decade $200B+ lifetime program value.
2. **Sentinel ICBM sole-source** — Replaces Minuteman III; multi-decade $140B+ program.
3. **National security space leadership** — Cygnus + classified space programs.
4. **Mission Systems radar/EW depth** — Sensors + electronic warfare leadership.

**Competitive positioning vs. peers:**
- **Lockheed Martin** — Larger; F-35 dominant; NGI competitor; Aegis.
- **RTX (Raytheon Technologies)** — Munitions + space + Pratt & Whitney engines.
- **General Dynamics** — IT services + munitions + naval.
- **Boeing Defense** — F-15EX + KC-46 + apache; recovering from execution issues.

**Structural advantages:**
1. **Backlog at record $95.7B** — Multi-year revenue visibility.
2. **Defense budget tailwind** — US FY2027 budget request proposes +44% increase; NATO 2% commitments + Pacific deterrence buildup.
3. **B-21 + Sentinel multi-decade programs** — Long-lifecycle revenue streams; high switching costs.
4. **Mission Systems mix** — Higher-margin technology content vs. heavy industrial.

**Challenges:**
- **Sentinel restructuring overhang** — Multi-billion overruns, Department of Defense oversight; could continue compressing margins.
- **Space Systems -8.2% in FY25** — Off legacy program rolls + Sentinel restructuring.
- **B-21 cost overruns** — Fixed-price LRIP contract creates margin risk.
- **Supply chain + workforce constraints** — Critical components, skilled labor shortages.

#### Key Facts
- Founded: 1939 (Northrop Aircraft); 1994 merger with Grumman
- Headquarters: Falls Church, Virginia
- Employees: ~100,000+
- Exchange: NYSE
- Sector / Industry: Industrials / Aerospace & Defense
- Market Cap: ~$80B
- FY2024 Revenue: $41.0B (+4%)
- FY2025 Revenue: ~$44B
- Backlog: $95.7B record
- B-21 Production Acceleration: 25% capacity increase agreement
- Q1 2026 Revenue: $9.9B; EPS $6.14
- 2026 Revenue Guide: $43.5–44.0B
- 2026 Segment Operating Margin Guide: Low-to-mid 11% range
- FY2025 Free Cash Flow: $3.3B (+26% YoY)
- Dividend Yield: ~1.5%
- CEO: Kathy Warden (since 2019)

## Recent Catalysts

---
ticker: NOC
step: 12
generated: 2026-05-12
source: quick-research
---

### Northrop Grumman Corporation (NOC) — Investment Catalysts & Risks

#### Bull Case Drivers

1. **B-21 Raider 25% production acceleration agreement** — Multi-billion-dollar incremental program value over the next decade. $200M near-term + $2.5B multi-year capex commitment. Material revenue impact in 2027-28 not in current guidance — pure upside.
2. **Record $95.7B backlog** — Multi-year revenue visibility unmatched in defense. Book-to-bill >1.1x sustainable.
3. **US defense budget tailwind** — FY2027 request proposes 44% increase; sustained Pacific + Ukraine + Israel demand; NATO 2% commitments; Middle East deterrence buildup.
4. **Sole-source on multiple strategic programs** — B-21, Sentinel ICBM, NGI, classified space, Triton — these are not contestable; multi-decade revenue streams.
5. **Mission Systems +9.7% growth** — Higher-margin radar + EW + sensors growing fastest; tech-content mix improving.
6. **Munitions expansion** — Ukraine + Israel + Pacific demand driving multi-year munitions capacity expansion (AARGM-ER, Hellfire, Stand-In Attack Weapon, etc.).
7. **Sentinel restructuring concludes late 2026** — Removes a multi-quarter overhang; margins should expand as restructuring costs roll off.
8. **CCA (Collaborative Combat Aircraft) emerging program** — Autonomous wingmen for F-35/NGAD; potential multi-billion program win in 2027.
9. **Free Cash Flow +26% in FY25 to $3.3B** — Cash generation accelerating despite Sentinel restructuring drag.
10. **Capital return $3B+ annually** — ~$1.6B buybacks + ~$1.4B dividends; sustainable through cycle.

#### Bear Case Risks

1. **B-21 cost overruns under fixed-price LRIP contracts** — Low-Rate Initial Production contracts are fixed-price; further cost overruns directly hit Aeronautics margins. B-21 has already taken meaningful charges.
2. **Sentinel ICBM continued overruns** — Multi-billion overruns through 2024-25; Department of Defense oversight intensifying; restructuring could miss late-2026 conclusion timeline.
3. **Space Systems -8.2% in FY25** — Off legacy program rolls + Sentinel restructuring; Space could continue underperforming through 2026.
4. **Defense budget political uncertainty** — Continuing resolutions + debt ceiling fights + administration changes create budget execution risk despite proposed budget growth.
5. **Workforce / supply chain constraints** — Critical components, skilled labor shortages for B-21, Sentinel, and munitions production ramp.
6. **Cyclical commercial space exposure** — Cygnus ISS resupply dependent on NASA budget + space launch cadence.
7. **Foreign Military Sales execution** — Multi-year sales cycles with allied governments; geopolitical timing risk.
8. **Premium valuation (~21x FY26 P/E)** — Defense sector premium; multiple compression if growth disappoints.

#### Upcoming Events
- **Q2 2026 earnings (late July 2026)**: Mid-year guide check + Sentinel restructuring progress.
- **Q3 2026 earnings (late October 2026)**: B-21 acceleration timing + CCA program updates.
- **Sentinel restructuring conclusion (late 2026)**: Critical overhang removal.
- **CCA program awards**: Air Force decisions on Collaborative Combat Aircraft contracts.
- **FY2027 Defense Budget appropriations**: Multi-quarter visibility on production funding.
- **Sentinel test launch (2027)**: Major program milestone.
- **B-21 IOC (Initial Operational Capability)**: 2029 target.

#### Analyst Sentiment
Consensus rating is **Buy / Overweight** (~65% Buy, 32% Hold, 3% Sell). Price targets cluster $650–720 vs. trading ~$555–585 (~12–25% implied upside). Bull case targets ~$800 on B-21 acceleration + Sentinel resolution + CCA awards; bear case ~$480 on Sentinel overruns + B-21 cost issues. Wells Fargo, Bernstein, JPM, Morgan Stanley maintain Buy/Overweight; Truist at Buy; Goldman at Buy.

#### Research Date
Generated: 2026-05-12

## Full Investment Thesis (Premium)

The full research tier adds these thesis-critical dimensions:

- Moat Analysis — durable competitive advantages, switching costs, network effects
- Investment Thesis — variant perception, what has to be true, why market may be wrong
- Bull / Base / Bear Scenarios — probability weights, catalysts, price targets
- Risk Register — macro, competitive, execution, regulatory risks with materiality ratings
- Management Quality — capital allocation track record, incentive alignment
- DCF Valuation — 10-year model with sensitivity matrix

**API endpoint:** GET /api/v1/research/NOC/memo

## Navigation

- Overview: /stocks/NOC
- Financials: /stocks/NOC/financials
- Thesis (this page): /stocks/NOC/thesis
- Investment Memo: /stocks/NOC/memo
- Coverage universe: /stocks